| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Common Stock | Options Exercise | $0 | +26.6K | +5.65% | $0.00 | 496K | 01 Feb 2025 | Direct | |
| transaction | LLY | Common Stock | Tax liability | -$9.65M | -11.9K | -2.4% | $811.08 | 484K | 01 Feb 2025 | Direct | |
| holding | LLY | Common Stock | 59.5K | 01 Feb 2025 | By David A. Ricks 2022 GRAT | ||||||
| holding | LLY | Common Stock | 68.7K | 01 Feb 2025 | By David A. Ricks SLAT | F1 | |||||
| holding | LLY | Common Stock | 300 | 01 Feb 2025 | By Trust | F1 | |||||
| holding | LLY | Common Stock | 7.26K | 01 Feb 2025 | 401(k) |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Restricted Stock Unit | Options Exercise | $0 | -26.6K | -100% | $0.00 | 0 | 01 Feb 2025 | Common Stock | 26.6K | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |